Bruton’s tyrosine kinase inhibition – an emerging therapeutic strategy in immune-mediated dermatological conditions

180.

Mendes-Bastos, P.+, Brasileiro, A., Kolkhir, P., Frischbutter, S., Scheffel, J., Moñino-Romero, S., and Maurer, M.: Bruton’s tyrosine kinase inhibition – an emerging therapeutic strategy in immune-mediated dermatological conditions. Allergy 2022: 77; 2355-2366. IF: 12.40

r.180